Comparison of Three Consecutive Monthly Administrations Between Aflibercept 8 mg and Brolucizumab 6 mg in Polypoidal Choroidal Vasculopathy
<b>Purpose:</b> The aim was to compare the short-term outcomes of aflibercept 8 mg and brolucizumab for the treatment of polypoidal choroidal vasculopathy (PCV). <b>Methods:</b> This study included 48 eyes of 48 patients with PCV. Drug selection was based on the treatment period. Sixteen eyes receiv...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
MDPI AG
2025-11-01
|
| Σειρά: | Pharmaceuticals |
| Θέματα: | |
| Διαθέσιμο Online: | https://www.mdpi.com/1424-8247/18/12/1811 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|